Citigroup profit triples in 1Q, tops estimates; revenue down

Thursday, April 15, 2021 | Ken Sweet, AP Business Writer


A Citibank office is open, Wednesday, Jan. 13, 2021 in New York. The nation’s largest banks are expected to report big profits for the first quarter, Tuesday, April 13, amid renewed confidence that pandemic-battered consumers and businesses can repay their debts and start borrowing again (AP Photo/Mark Lennihan)

NEW YORK (AP) — Citigroup's profits more than tripled in the first quarter, the banking conglomerate said Thursday, helped by the release of billions of dollars from its loan-loss reserves. The bank also announced plans to scale back its global consumer banking franchise outside the U.S.

The New York-based company said it earned a profit of $7.94 billion, or $3.62 per share, compared to a profit of $2.54 billion, or $1.06 a share, in the same period a year earlier. The bank's profits were well above the $2.60 per share that analysts had been looking for, according to FactSet.

Like its major Wall Street competitors, Citigroup was able to release billions from its loan-loss reserves this quarter, which directly benefited its bottom line. The big banks collectively set aside tens of billions of dollars a year ago to cover the potential losses they might incur as the economy nosedived in the early months of the pandemic. Now that the economy is recovering, banks are able to release those funds.

Citi had a $3.85 billion one-time gain from releasing its loan-loss reserve, which the bank said “reflects the improving economic outlook.”

Citigroup saw lower revenue and interest income in its global banking division, as its customers more aggressively paid down their debts in the past year during the pandemic. Citi has a substantial credit card business that leans toward “revolving” customers — those who keep a steady balance on their cards — and a significant chunk of Americans used their government stimulus payments to pay down debt. Revenues from credit cards fell 18% from a year ago.

Citi's investment banking division had a strong quarter, albeit not as strong as its competition at JPMorgan Chase and Goldman Sachs. Revenues across the division were up 5%, helped by a jump in revenues from its stock trading department.

Part of that revenue gain in the investment bank came from the growing interest in SPACs, or special purpose acquisition companies, which have become a popular way for companies to go public. Citi has underwritten several SPAC initial public offerings.

In a separate announcement, the bank said it would be slimming down its global consumer banking franchise to focus on four geographic markets: Singapore, Hong Kong, the United Arab Emirates and London. The change does not impact the company's U.S. consumer banking operations.

Citi has historically had a large consumer banking presence outside the U.S., but it tends to dabble in markets instead of dominating in them. The scaling back is partly to give Citi leverage and focus in the markets it says it sees as best for future growth.

Featured Article: Options Trading



7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Citigroup (C)2.7$75.13+0.1%2.72%14.94Buy$76.40
JPMorgan Chase & Co. (JPM)2.5$161.220.0%2.23%21.07Buy$147.99
The Goldman Sachs Group (GS)2.2$368.68-0.6%1.36%15.53Buy$358.19
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.